Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Principia Biopharma logo

Principia Biopharma

Recent Finacing

Series B

Recent Raise

$50M

Principia Biopharma is a biopharmaceutical company that discovers and develops reversible-covalent small-molecule inhibitors for autoimmune, inflammatory diseases and oncology, including oral BTK, FGFR and IL-17 programs.

Founded 2008
California, United States
51-100
Publicly Traded
principiabio.com

Highlights

Focus Areas

Biopharma
Biotechnology
Life Science
Oncology

Recent Investors

OrbiMed logo
New Leaf Venture Partners logo
Mission Bay Capital logo
Morgenthaler Ventures logo
SR One logo
Sofinnova Ventures logo

Financials

$62.5M

Total Raised

2

Funding rounds

6

Investors